REG - OptiBiotix Health - First products in Whole Foods Market Inc <Origin Href="QuoteRef">OPTIO.L</Origin>

OptiBiotix HealthAnnouncement

09/08/2016 07:05

RNS Number : 5880G
OptiBiotix Health PLC
09 August 2016
OptiBiotix Health plc
("OptiBiotix" or the "Company")
First products in Whole Foods Market Inc
OptiBiotixHealthplc(AIM:OPTI),alifesciencesbusinessdevelopingcompoundstotackleobesity,highcholesterol,
diabetes and skin care, announces that GoFigure meal replacement shakes and natural snack bars products are now available for sale in UK stores of the Whole Foods Market Inc, a large ($15bn turnover in 2015) American supermarket chain exclusively featuring healthy foods.
On 26 July 2016, OptiBiotix announced it had completed an investment to acquire 51% of The Healthy Weight Loss Company which produces GoFigure products containing SlimBiome, OptiBiotix's patented combination of natural ingredients, identified and developed by experts to support weight loss. The launch of SlimBiome in the GoFigure range establishes its use in food products with customer feedback consistently reporting reduced hunger, less snacking, and easier weight loss. GoFigure products will initially be stocked in 8 UK Whole Foods Market Inc shops with opportunities for further expansion.
Stephen O'Hara, CEO of OptiBiotix, commented:"Following the success of our online launch we are delighted to have GoFigure products on the shelves in such a large and well known American supermarket chain. This is the first retail listing ofGoFigure products in the UK and we hope the precursor for future national and international listings. The listing expands the range of commercial opportunities for Slimbiome both as a food or ingredient and dietary supplement."
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
For further information, please contact:
OptiBiotix Health plc
www.optibiotix.com
Stephen O'Hara, Chief Executive
Contact via Walbrook below


Cairn Financial Advisers LLP
 Tel: 020 7148 7900
Liam Murray



Hybridan LLP (Joint Broker)
Tel: 0203 764 2341
Claire Louise Noyce



Peterhouse Corporate Finance Ltd (Joint Broker)
Tel: 020 7469 0936
Lucy Williams / Duncan Vasey



Walbrook PR Ltd
Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy
Mob: 07876 741 001
About OptiBiotix - www.optibiotix.com 
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. 
The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. 
OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases. 
Whole Foods Market Inc. is an American supermarketchain exclusively featuring foods without artificial preservatives, colors, flavors, sweeteners, and hydrogenated fats.[ As of 2015 it had 91,000 employees, $15.4bn revenue (2015), and 431 supermarkets in the United States, Canada, and the United Kingdom.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
MSCFMGGRKRLGVZM